Enterprise Financial Services Corp Pfizer Inc Transaction History

Enterprise Financial Services Corp

$167 Million
Q1 2025

A detailed history of Enterprise Financial Services Corp transactions in Pfizer Inc stock. As of the latest transaction made, Enterprise Financial Services Corp holds 22,508 shares of PFE stock, worth $525,561. This represents 0.34% of its overall portfolio holdings.

Number of Shares

22,508

Previous 19,951 12.82%

Holding current value

$525,561

Previous $529,000 7.75%

% of portfolio

0.34%

Previous 0.3%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	BUY	$25.01 - $27.13 $63,950 - $69,371	2,557 Added 12.82%	22,508 $570,000
Q4 2024 Feb 07, 2025	SELL	$24.8 - $30.19 $104,953 - $127,764	-4,232 Reduced 17.5%	19,951 $529,000
Q3 2024 Nov 12, 2024	SELL	$27.7 - $31.39 $80,800 - $91,564	-2,917 Reduced 10.76%	24,183 $699,000
Q2 2024 Aug 13, 2024	SELL	$25.26 - $29.6 $46,301 - $54,256	-1,833 Reduced 6.34%	27,100 $758,000
Q1 2024 May 14, 2024	SELL	$25.89 - $29.73 $138,071 - $158,550	-5,333 Reduced 15.56%	28,933 $802,000
Q4 2023 Feb 09, 2024	SELL	$26.13 - $33.94 $526,284 - $683,585	-20,141 Reduced 37.02%	34,266 $986,000
Q3 2023 Oct 31, 2023	SELL	$32.09 - $37.51 $10,076 - $11,778	-314 Reduced 0.57%	54,407 $1.8 Million
Q2 2023 Aug 11, 2023	SELL	$36.12 - $41.79 $15,387 - $17,802	-426 Reduced 0.77%	54,721 $2.01 Million
Q1 2023 May 15, 2023	SELL	$39.39 - $51.28 $34,663 - $45,126	-880 Reduced 1.57%	55,147 $2.25 Million
Q4 2022 Feb 14, 2023	SELL	$41.75 - $54.5 $73,855 - $96,410	-1,769 Reduced 3.06%	56,027 $2.87 Million
Q3 2022 Nov 14, 2022	SELL	$43.76 - $53.42 $10,283 - $12,553	-235 Reduced 0.4%	57,796 $2.53 Million
Q2 2022 Aug 09, 2022	BUY	$46.53 - $55.17 $107,670 - $127,663	2,314 Added 4.15%	58,031 $3.04 Million
Q1 2022 May 16, 2022	SELL	$45.75 - $56.69 $32,802 - $40,646	-717 Reduced 1.27%	55,717 $2.88 Million
Q4 2021 Feb 14, 2022	SELL	$41.32 - $61.25 $564,844 - $837,287	-13,670 Reduced 19.5%	56,434 $3.33 Million
Q3 2021 Nov 15, 2021	BUY	$39.25 - $50.42 $265,133 - $340,587	6,755 Added 10.66%	70,104 $3.02 Million
Q2 2021 Aug 16, 2021	BUY	$35.91 - $40.68 $160,984 - $182,368	4,483 Added 7.62%	63,349 $2.48 Million
Q1 2021 May 13, 2021	BUY	$33.49 - $37.77 $10,047 - $11,331	300 Added 0.51%	58,866 $2.13 Million
Q4 2020 Feb 12, 2021	SELL	$33.47 - $42.56 $31,361 - $39,878	-937 Reduced 1.57%	58,566 $2.16 Million
Q3 2020 Nov 13, 2020	SELL	$31.75 - $37.25 $260,762 - $305,934	-8,213 Reduced 12.13%	59,503 $2.18 Million
Q2 2020 Aug 04, 2020	SELL	$30.12 - $36.54 $26,746 - $32,447	-888 Reduced 1.29%	67,716 $2.21 Million
Q1 2020 May 15, 2020	BUY	$27.03 - $38.62 $13,785 - $19,696	510 Added 0.75%	68,604 $2.24 Million
Q4 2019 Jan 28, 2020	SELL	$32.92 - $37.36 $109,031 - $123,736	-3,312 Reduced 4.64%	68,094 $2.67 Million
Q3 2019 Oct 31, 2019	SELL	$32.49 - $42.13 $18,129 - $23,508	-558 Reduced 0.78%	71,406 $2.57 Million
Q2 2019 Jul 30, 2019	BUY	$36.98 - $41.52 $16,197 - $18,185	438 Added 0.61%	71,964 $3.12 Million
Q1 2019 Apr 26, 2019	BUY	$37.5 - $41.2 $1.4 Million - $1.54 Million	37,362 Added 109.36%	71,526 $3.04 Million
Q4 2018 Jan 25, 2019	SELL	$38.47 - $43.86 $40,431 - $46,096	-1,051 Reduced 2.98%	34,164 $1.49 Million
Q3 2018 Oct 26, 2018	SELL	$34.47 - $41.81 $35,159 - $42,646	-1,020 Reduced 2.81%	35,215 $1.55 Million
Q2 2018 Jul 27, 2018	SELL	$32.98 - $35.16 $37,003 - $39,449	-1,122 Reduced 3.0%	36,235 $1.32 Million
Q1 2018 Apr 27, 2018	SELL	$31.91 - $37.02 $18,603 - $21,582	-583 Reduced 1.54%	37,357 $1.33 Million
Q4 2017 Jan 26, 2018	SELL	$33.26 - $35.29 $25,344 - $26,890	-762 Reduced 1.97%	37,940 $1.37 Million
Q3 2017 Oct 27, 2017	BUY	$31.0 - $34.15 $1.2 Million - $1.32 Million	38,702	38,702 $1.38 Million

Others Institutions Holding PFE

# of Institutions

3,369

Shares Held

3.61B

Call Options Held

102M

Put Options Held

130M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $131B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Enterprise Financial Services Corp, based on Form 13F filings with the SEC.

News

Stay updated on Enterprise Financial Services Corp with notifications on news.

Account

Enterprise Financial Services Corp Pfizer Inc Transaction History